Healthcare firm reaps rewards of spending on manufacturing facilities

Steve Woodhead

An investment in design, manufacturing and assembly functions at a healthcare business has allowed it to diversify and manufacture its own range of core products.

A planned £200,000 investment by Doncaster-based company, Intastop Ltd, which has a customer reach across the UK and Europe, has seen it become self-sufficient, in turn driving greater efficiencies.

Its spending backed was by a Business Productivity Grant via the Local Authority and the European Union.

Steve Woodhead, managing director, Intastop Ltd, said: “This investment heralds the next chapter in the history of Intastop and it is already delivering a significant positive impact on the way the business operates.

“No longer do we have to rely on a supplier based outside of the UK, which didn’t really fit with the Intastop vision and business strategy any longer.

“This was the catalyst for the investment and now it has removed a lengthy supply chain process for our business and allowed us to bring the business to Yorkshire.”

The changes have allowed for new equipment, training, tooling, new CRM/MRP systems and a manufacturing excellence programme which will drive an increased turnover ahead of further strategic growth plans.

Woodhead added: “Our vision for continuous improvement and growth has seen us increase by 60% in the last five years and this change in direction will allow us to capitalise on this further.

“Over the years we have shifted from a business that was heavily weighted towards warehousing and distribution to a company that is driving forward innovation, design and investment not only in our business but in the wider healthcare and anti-ligature market to support major policies in areas such as healthcare infection control, mental health provision and building design and maintenance.”

Over the next five years Intastop plans to expand its product range of door, wall and people protection, through ongoing research and development.

In addition, with a foothold firmly in the mental health solutions market in the UK, Intastop is also set to roll out its export strategy to international markets.